TCL Archive Hammer Gives $100,000 to Expand Rosenberg’s T-Cell Growth Factor Clinical Studies March 1, 1985
TCL Archive NCI Programs: Institute To Develop Plans For Large Trial Of Spiral CT Scanning For Lung Cancer November 5, 1999
TCL Archive AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation. April 14, 2006
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004